Prasugrel Versus Placebo in Adult Sickle Cell Disease

NCT01167023 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle Cell Anemia

Interventions

DRUG: Prasugrel
DRUG: Placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]